Cipher Pharmaceuticals is about to release its latest earnings report, and investors are curious to see if the company can keep up its streak of positive surprises.
Recent earnings trend
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeAdvertisement
Market cap
$445.62M
P/E
10.5x
52W high
$20.56
52W low
$12.48
1W change
+4.28%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 17.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+17.6% Upside
Current Price
C$17.55
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
24.3%
Annualized
90-Day Vol
32.4%
Annualized
Trend (90d)
-10.6%
Annualized drift
90d Mean
C$16.90
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$17.33 | C$15.93 โ C$18.85 |
| 60 trading days | C$17.11 | C$15.20 โ C$19.27 |
| 90 trading days | C$16.90 | C$14.61 โ C$19.54 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 2 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 4 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-11 | โ | 0.2600 | โ |
| 2026-03-31 | 2026-05-07 | 0.3300 | 0.2200 | +50.0% |
| 2025-12-31 | 2026-03-12 | 0.6900 | 0.2100 | +228.6% |
| 2025-09-30 | 2025-11-06 | 0.3000 | 0.1700 | +76.5% |
| 2025-06-30 | 2025-08-07 | 0.3000 | 0.2200 | +36.4% |
| 2025-03-31 | 2025-05-08 | 0.1400 | 0.1500 | -6.7% |
On August 11, 2026, Cipher Pharmaceuticals Inc (CPH.TO) will announce its earnings for the fiscal period ending June 30, 2026. With a solid history of exceeding earnings estimates, this upcoming report is generating significant interest among investors. This preview will look into the expected performance metrics and the broader business context surrounding Cipher Pharmaceuticals.
Investor takeaway: Cipher Pharmaceuticals has consistently shown strong performance. Although analysts have lowered their EPS expectations for the upcoming report, the company's track record suggests it could still deliver a positive surprise.
Upcoming EPS Estimate: $0.26
Cipher Pharmaceuticals has beaten earnings estimates in the last four quarters, with an average surprise of 73.75%, demonstrating its ability to consistently outperform expectations.
Advertisement
Bull case
Cipher's recent earnings history shows a clear pattern of exceeding estimates significantly, with a surprise of over 50% in the last reported quarter. This trend, along with a strong profit margin of 60.60%, highlights the company's operational strength and potential for continued growth.
Bear case
Despite Cipher's impressive past performance, analysts have lowered their EPS consensus from $0.30 to $0.24. If the company fails to meet even this reduced expectation, it could raise concerns about its growth trajectory and market position.
Earnings Expectations
โ
Historical Performance
โ
Analyst Sentiment
โ
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
